Bausch Health Companies Inc (BHC) support and resistance · rev $5.38B
Bausch Health Companies Inc (BHC) is a drug manufacturers - specialty & generic company listed on NYSE.
This page maps Bausch Health Companies Inc (BHC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BHC revenue for 2026-06-30 was $5.38B. Net income was -$1.17B. BHC currently screens at market cap $1.78B.
BHC currently screens at market cap $1.78B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BHC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BHC quote page for the session range and the stock page for the full model.
Not investment advice.